we live in the future – the next step is designing large gene insertions and fine scale editing with AI @ProfluentBio “One dose of VERVE-102 (in vivo base editor) led to dose-dependent, substantial, and sustained reductions in PCSK9 and LDL cholesterol levels.”
AI enables large gene insertions and fine-scale editing for cholesterol reduction
By
–
